23 May 2013
Keywords: depomed, completes, ph, ii, metformin, gr, analysis
Article | 09 August 2001
DepoMed has completed its Phase II data analysis for its once-dailymetformin gastric retention system, comparing it to Bristol-Myers Squibb
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 August 2001
10 August 2001
© 2013 thepharmaletter.com